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ORIGINAL RESEARCH
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Aims: Cigarette smoking is one of the strongest risk factors for stroke. However, the underlying 
molecular mechanisms that smoke leads to the pathogenesis of stroke are incompletely 
understood.
Methods: Dimethyl sulfoxide (DMSO)-soluble (lipid-soluble) cigarette smoking particles (DSP) 
were extracted from cigarette smoke (0.8 mg nicotine per cigarette; Marlboro®). Rat cerebral 
arteries were isolated and organ cultured in the presence of DSP (0.2 μl/ml, equivalent to the 
plasma level in smokers) for 24 h. The expression of matrix metalloproteinase 9 and 13 (MMP9 
and MMP13), angiotensin receptor 1 and 2 (AT1 and AT2), interleukin 6 and inducible nitric 
oxide synthase (iNOS) were investigated at mRNA level by real-time PCR and/or at protein 
level by immunohistochemistry. In addition, the activity of three mitogen-activated protein 
kinases (p38, ERK 1/2 and SAPK/JNK) and their downstream transcription factors (ATF-2, 
Elk-1 and c-Jun) were examined.
Results: We observed that compared with control (DMSO-treated cerebral arteries), the cerebral 
arteries treated by DSP exhibited enhanced expression of MMP13 and AT1 receptors, but not of 
AT2 receptors, at both mRNA and protein levels, suggesting that a transcriptional mechanism is 
most likely involved in the DSP effects. This is further supported by the ﬁ  ndings that DSP induced 
phosphorylation of p38 mitogen-activated protein kinases inﬂ  ammatory signal protein in parallel 
with activation of its downstream transcription factor ATF-2 and Elk-1. However, ERK 1/2 and 
SAPK/JNK activities were markedly expressed in the control (organ culture per se with DMSO), and 
DSP failed to further enhance the activation of ERK 1/2 and SAPK/JNK in the cerebral arteries.
Conclusions: DSP induces cerebral vessel inﬂ  ammation with activation of p38 MAPK inﬂ  am-
matory signal and the downstream transcriptional factors (ATF-2 and Elk-1) in parallel with 
enhanced extracellular-matrix-related gene transcription and increased AT1 receptor expression 
in the cerebral arteries, which are key events in stroke pathogenesis.
Keywords: cigarette smoking, vascular inﬂ  ammation, signal transduction, extracellular matrix, 
MMP, stroke
Introduction
Cigarette smoke is well-known to increase risk for stroke.1 An epidemiologic follow-up 
study shows that the risk was signiﬁ  cantly increased in smokers for all strokes includ-
ing a further increased risk in ischemic stroke among cigarette-smoking women with 
a cigarette-smoking spouse.2 Cigarette smoke leads to an increased risk of aneurismal 
subarachnoid hemorrhage (SAH).3 Smoking is associated with increased ﬁ  brinogen con-
centration,4 enhanced platelet agglutinability5 and reduced ﬁ  brinolytic activity,6 as well as 
with increased cerebrovascular constriction.7 The molecular mechanisms to explain how 
smoking increases the risk for both ischemic and hemorrhage strokes are still elusive.
Mitogen-activated protein kinases (MAPK) are key intracellular inﬂ  ammatory signal 
molecules that can be activated by inﬂ  ammatory cytokines, growth factors, and stress. Vascular Health and Risk Management 2009:5 334
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These kinases are known to be involved in upregulation of 
matrix metalloproteinases (MMP) transcription in the smooth 
muscle cells8 and enhanced expression of vascular G-protein 
coupled receptors (GPCR) such as angiotensin II receptor 1 
(AT1) and contractile endothelin type B (ETB) receptors in the 
cerebral arteries in stroke.9 The present study was designed to 
test the hypothesis that dimethyl sulfoxide (DMSO)-soluble 
(lipid-soluble) cigarette smoke particles (DSP) may induce acti-
vation of the MAPK-mediated inﬂ  ammatory signal pathways, 
the enhanced expression of extracellular-matrix-related genes 
and upregulation of AT receptors in the cerebral arteries. These 
are key events that have been seen in cerebral ischemic stroke 
in man,10 in experimental middle cerebral artery occlusion9,11,12 
and in SAH.13,14
Previously, we have used an in vitro organ culture of 
cerebral artery model as a surrogate for studying cerebrovas-
cular receptor changes in stroke and observed that ERK 1/2 
MAPK is activated during the organ culture and this occurred 
in parallel with enhanced contractile ETB receptor expression 
in the cerebral arteries.15 In the mesenteric arteries, organ 
culture in the presence of DSP induced further activation of 
MAPK-mediated intracellular inﬂ  ammatory signaling and 
additional enhancement of transcription for contractile ETB 
receptors in the smooth muscle cells.16 Furthermore, we have 
demonstrated that a transcriptional mechanism dependent 
on activation of MAPK-mediated inﬂ  ammatory signaling is 
involved in the DSP toxic effects on the mesenteric arteries.16 
By using the same organ culture model, the present study 
demonstrates a similar mechanism that might be involved in 
smoke-induced cerebral vessel dysfunctions and damage, key 
events in pathogenesis of stroke. This is based on our ﬁ  ndings 
that organ culture of cerebral arteries in presence of DSP can 
also induce activation of p38 MAPK inﬂ  ammatory signal-
ing and its downstream transcriptional factors (ATF-2 and 
Elk-1), enhance expression of extracellular-matrix-related 
genes (MMP9 and MMP13) and increase vascular AT1 recep-
tor expression at both mRNA and protein levels.
Materials and methods
DMSO-lipid soluble cigarette smoking 
particles extraction
Three cigarettes (0.8 mg nicotine per cigarette; Marlboro®, 
Philip Morris USA, Pittsburgh, PA, USA) were “smoked” 
by a water aspirator, and the smoke directed through a cotton 
wool ﬁ  lter. The cigarette smoke particles, retained in the ﬁ  lter, 
were dissolved in 1 ml DMSO for detailed description of the 
procedure see Grandström and colleagues.17 Preliminary tests 
revealed no effects of water-soluble cigarette smoke particles 
and thus attention was directed to the DSP preparation. The 
dose chose of DSP was based on our previous study.16 0.2 μl/
ml of DSP (containing 20 ng/ml of nicotine), equivalent to 
the plasma level in smokers, was used.18,16
Vessel preparation
Male Sprague Dawley rats weighing 250–300 g were eutha-
nized by CO2, the middle cerebral artery (MCA) and basilar 
artery (BA) were dissected out. The arteries were either 
used directly (0 hours) or were placed for 24 h in 5 ml of 
Dulbecco’s Modiﬁ  ed Eagle Medium (DMEM) in an incuba-
tor set to 37 °C containing 5% CO2. Prior to incubation 1 μl 
of DMSO (control) or DSP was mixed with 5 ml of DMEM 
(without DMSO or saline instead gave similar results; data not 
shown). The cerebral vessel segments were then frozen instan-
taneously by the use of a freezer spray (Shandon, Houston, 
TX, USA) and stored at −80 °C until RNA preparation took 
place or used for immunohistochemistry (see below).
RNA isolation
Following the manufacturer’s protocols, total RNA prepara-
tions were obtained using the TRIzol® RNA isolation kit 
(Invitrogen, Carlsbad, CA, USA). Brieﬂ  y, the arteries were 
homogenized using TissueLyser (VWR, Stockholm, Sweden). 
The homogenates were then suspended in 1 ml of Trizol 
(Invitrogen, Stockholm, Sweden) and were centrifuged at 
12,000 RPM at 4 °C for 15 min to remove debris. The super-
natant was transferred to a different tube and the rest was 
discarded. The samples were then incubated for 5 min at room 
temperatures and ﬂ  icked every 30 sec. To remove all traces of 
phenol, 300 μl of chloroform was added and the samples were 
mixed by inversion. Then, the samples were incubated at room 
temperature again for 2–3 min, followed by 15 min centrifuga-
tion at 12,000 g at 4 °C. The upper phase was collected and the 
rest was discarded. Chloroform was again added to remove 
all traces of phenol and the samples were spun at 12000 g at 
4 °C for 5 min. The RNA was precipitated by addition of an 
equal amount of isopropanol and was incubated overnight 
at −80 °C. The RNA was subsequently pelleted at 12,000 g 
for 20 min at 4 °C. The RNA was re suspended in 10 μl of 
nuclease free water, the 260/280 values being measured using 
a GeneQuant Pro spectrophotometer (Amersham Pharmacia 
Biotech, Uppsala, Sweden).
Real-time PCR investigation
The cDNA for the real-time polymerase chain reactions (PCR) 
were created in 40 μl reactions using SuperScript® III in accor-
dance with the manufacturer’s instructions (Perkin-Elmer, 
Applied Biosystems, Foster City, CA, USA). One μg of RNA Vascular Health and Risk Management 2009:5 335
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was used in each reaction. The subsequent real-time PCR was 
performed in a GeneAmp 5700 Sequence Detection system 
(Perkin-Elmer, Applied Biosystems) using the GeneAmp 
SYBR® Green kit (Perkin-Elmer, Applied Biosystems) with 
a 25 μl reaction volume and 1 μl of the above mentioned 
cDNA serving as a template. Each reaction was performed in 
duplicate and was run for 40 cycles. β-actin and elongation 
factor 1 (EF-1) were used as housekeeping genes. The gene 
expressions were normalized versus the housekeeping genes 
to account for differences in the starting material and in the 
cDNA reaction efﬁ  ciency; for a more detailed account of the 
procedure see Hansen-Schwartz and colleagues.19 Each primer 
pair was speciﬁ  c for the genes of interest (Table 1).
DAB immunohistochemistry
The rat MCA was dissected out, treated as described above 
and placed in Tissue TEK (Gibco, Carlsbad, CA, USA), 
frozen and subsequently sectioned into 10 μm thick slices in 
a calibrated Microm HM500 M cryostat (Microm, Walldorf, 
Germany). The primary antibodies used were rabbit anti-
phospho p38 (#4631; Cell Signaling Technology Inc., 
Danvers, MA, USA), rabbit anti-phospho ERK 1/2 MAPK 
(#4376; Cell Signaling Technology Inc.), rabbit anti-phospho 
SAPK/JNK (#9251; Cell Signaling Technology Inc.) rabbit 
anti-phospho ATF-2 (#9221; Cell Signaling Technology Inc.), 
rabbit anti-phospho Elk-1 (#9181; Cell Signaling Technology 
Inc.) and rabbit anti-phospho c-Jun (#9261; Cell Signaling 
Technology Inc.) each diluted 1:50. The secondary antibod-
ies used were biotin-conjugated goat anti-rabbit antibodies 
(111-065-003; Jackson ImmunoResearch, Newmarket, 
Suffolk, UK) diluted 1:100. All dilutions were with phos-
phate buffer saline (PBS) containing 0.3% Triton-X100 and 
5% fetal calf serum. The Vectastain ABC kit (Vector Labora-
tories, Burlingame, CA, USA) together with DAB substrate 
(Rockland Immunochemicals Inc., Gilbertsville, PA, USA) 
was used for detection in accordance with the manufacturers’ 
instructions. Pictures were taken at 40 × magniﬁ  cation. Sec-
ondary antibodies alone served as a negative control.
After the arterial segments had been incubated in the pres-
ence of either DSP 0.2 μl/ml or DMSO 0.2 μl/ml (control) for 
24 h, they were cut into sections and stained with the DAB 
methods. For each vessel, six pre-directed sections were 
assessed according to the previously published protocol with 
slight modiﬁ  cations16,20 The DAB intensity was measured at 
six pre-directed preset areas in the smooth muscle cell layers. 
The mean intensity was obtained from four vessels. The 
DAB intensity measurement was rechecked by experienced 
senior co-workers.
Fluorescence immunohistochemistry
The rat MCA was dissected out, treated as described above 
and placed in Tissue TEK (Gibco), frozen and subsequently 
sectioned into 10 μm thick slices in a calibrated Microm 
HM500M cryostat (Microm). The primary antibodies were 
mouse anti-MMP13 (ab3208; Abcam, Cambridge, MA, USA) 
diluted 1:100, rabbit anti-human AT1 (sc-1173; Santa Cruz 
Biotechnology Inc., Santa Cruz, CA, USA) diluted 1:100, rabbit 
anti-human AT2 (sc-9040; Santa Cruz Biotechnology Inc). 
Table 1 Gene-speciﬁ  c primer sequences and accession numbers
Gene name Abbreviation Accession number Primer sequence
Beta-actin β-actin NM-031144 gtagccatccaggctgtgttg 
tgccagtggtacgaccagag
Elongating factor 1 EF-1 NM-175838 gcaagcccatgtgtgttgaa 
tgatgacacccacagcaactg
Interleukin 6 IL6 NM-012589 aagagacttccagccagttgcc 
actggtctgttgtgggtggtatc
Inducible no synthase iNOS NM-012611 caatggcttgaggcagaagc 
gccacctcggatatctcttgc
Matrix metalloproteinase 9 MMP9 NM-031055 aagccttggtgtggcacgac
tggaaatacgcagggtttgc
Matrix metalloproteinase 13 MMP13 M60616 tctgcaccctcagcaggttg
catgaggtctcgggatggatg
Angiotensin II receptor 1 AT1 NM-030985 ggtggagtgacaggttcaaagc
agggtgaatggtcctttggtc
Angiotensin II receptor 2 AT2 U01908 tctgttagtgggatgcatgtaatca 
tgtgggcctccaaaccattVascular Health and Risk Management 2009:5 336
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diluted 1:100. All dilutions were with PBS containing 10% fetal 
calf serum. The secondary antibodies were donkey antimouse 
Cy™ 5 conjugated (715-175-150; Jackson ImmunoRe-
search Inc.) 1:100 and donkey antirabbit Cy™ 3 conjugated 
(711-165-152; Jackson ImmunoResearch Inc.) diluted 1:100 
with PBS containing 10% fetal calf serum.
Picture analysis
We investigated the ﬂ  uorescence or DAB intensity using 
ImageJ v1.41 software (downloaded from http://rsb.info.
nih.gov/ij/). The mean intensity based on measurements in 
six parts of each segment is reported. The mean values of 
each vessel were used in calculating the mean at each point 
in time or treatment.
Statistics
Differences were investigated using the Mann–Whitney U test 
and p  0.05 being considered statistically signiﬁ  cant.
Results
mRNA expression studies
Gene expression was investigated by a real-time PCR in fresh 
MCA and BA following 24 h of organ culture using either 
DMSO or DSP. EF-1 and β-actin were used to normalize the 
results. Both housekeeping genes gave the same result after nor-
malization in both MCA and BA. The results are presented in 
terms of the mean regulation ± SEM as compared with 0 hour of 
incubation. Il-6, iNOS, MMP9, and MMP13 were investigated 
because of results from previous microarray studies.10,21 IL-6 
and iNOS were signiﬁ  cantly upregulated after 24 h of culture 
with vehicle, while we did not observe a further enhancement by 
DSP treatment. However, MMP9 and MMP13 did not change 
after 24 h of organ culture in presence of vehicle, but they were 
signiﬁ  cantly upregulated in the DSP-treated arteries (Figure 1). 
In addition, DSP caused a signiﬁ  cant enhancement of vascular 
AT1 receptor mRNA expression as compared with that of the 
DMSO-treated cerebral arteries (Figure 2), while this was not 
seen for AT2 receptor mRNA expression.
Signal transduction
Organ culture per se (without DMSO vehicle) has been 
studied before.15 Here, by using immunohistochemistry, we 
examined activation (phosphorylated) of intracellular signal 
molecule p38, ERK 1/2, SAPK/JNK and the downstream 
transcription factors ATF-2, Elk-1, and c-Jun. Compared with 
fresh arteries, the levels of pERK 1/2 and pSAPK/JNK were 
iNOS





















































































Figure 1 The expression of the inﬂ  ammatory genes tended to be greater in the cerebral arteries treated with DSP than in the cerebral arteries treated with DMSO control. 
There was a signiﬁ  cant upregulation of the extracellular-matrix-related genes (MMP9 and MMP13) in the DSP group, compared with DMSO control. The cerebral arteries have 
been organ cultured for 24 hours in the presence of DSP or DMSO (control).
Notes: Data presented as mean ± SEM, n = 4; *p  0.05.
Abbreviations: DMSO, dimethyl sulfoxide; DSP, cigarette smoke particles; MMP, matrix metalloproteinase; ns, not signiﬁ  cant.Vascular Health and Risk Management 2009:5 337
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elevated both in DMSO- and DSP-treated arteries, however, 
there was no signiﬁ  cant difference between the DMSO and 
DSP groups (Table 2). Activation of p38 was not seen in the 
fresh arteries (0 hour incubation) and there was only a slight 
increase in p38 activation after 24 h of culture in presence 
of DMSO. Interestingly, the DSP-treated arteries showed a 
signiﬁ  cant activation of p38, compared with both the fresh 
and DMSO-treated artery segments (Table 2; Figure 3).
The transcription factor ATF-2 activation showed a 
pattern similar to that of p38; there was no pATF-2 in fresh 
arteries whereas a distinct activation was evident in arteries 
incubated for 24 h together with DSP (Figure 3). In addition, 
DSP induced a strong activation of transcriptional factor 
Elk-1 (Figure 3) in the cerebral arteries. The transcription 
factor c-Jun was activated at same degree both in the DMSO-
treated and in the DSP-treated arteries (Table 2).
MMP13 and AT receptor expressions
The protein expression of MMP13 and AT receptors in the 
cerebral arteries was investigated by using immunohistochem-
istry. We observed these proteins were expressed mostly in the 
smooth muscle cells. An increase in the amounts of MMP13 
protein in the cerebral arteries (Figure 4) was consistent with 
the mRNA expression ﬁ  ndings. The amounts of AT1 receptor 
protein was also investigated due to the increased mRNA 
expression found. Compared with fresh arteries, the AT1 
receptor protein was elevated in DMSO group and further 
increased by DSP. But, this was not seen for the expression 
of AT2 receptors after DSP treatment (Figure 4).
Discussion
We have for the ﬁ  rst time demonstrated that in cerebral 
arteries, lipid-soluble cigarette smoke particles (DSP) induced 
activation of the p38 MAPK intracellular inflammatory 
signaling and phosphorylation of its downstream transcrip-
tional factors (ATF-2 and Elk-1), enhanced expression of 
extracellular-matrix-related gene MMP13 and upregulation of 
vascular AT1 receptors at both mRNA and protein levels. Our 
ﬁ  ndings suggest that the p38 MAPK-mediated inﬂ  ammatory 
signaling is most likely involved in the DSP toxic effects on the 
cerebral arteries. In agreement with this, we have previously 
observed that DSP could activate the MAPK inﬂ  ammatory sig-
naling-mediated transcriptional mechanisms and subsequently 
resulted in upregulation of contractile ETB receptor expression 
in the smooth muscle cells of mesenteric arteries.16 In addition, 
we have linked DSP-induced activation of p38 pathways to 
the ETB upregulation by speciﬁ  c inhibition of p38 activity, 
which demonstrates that p38 MAPK-mediated transcriptional 
mechanisms are involved in the ETB upegulation.16 In the 
present study, DSP may induce the increased expression of 
MMPs via similar mechanisms through phosphorylation of 
p38 and activation of its downstream transcription factors 
(ATF-2 or ElK-1).
AT1
































Figure 2 The expression of angiotensin II receptors in the cerebral arteries following organ culture with DSP or DMSO (control), there was a signiﬁ  cant upregulation of the 
AT1 receptors induced by DSP compared with DMSO.
Notes: Data presented as mean ± SEM, n = 4; *p  0.05.
Abbreviations: AT, angiotensin receptor; DMSO, dimethyl sulfoxide; DSP, cigarette smoke particles; ns, not signiﬁ  cant.
Table 2 Phosphorylation of intracellular signal proteins induced 
by DSP
Fresh DMSO-treated DSP-treated
p-p38 1 ± 0.26 1.15 ± 0.38 1.81 ± 0.26*
p-ERK 1/2 1 ± 0.18 1.58 ± 0.13 1.83 ± 0.40
p-SAPK/JNK 1 ± 0.03 1.51 ± 0.34 1.79 ± 0.09
p-ATF-2 1 ± 0.12 1.14 ± 0.09 1.61 ± 0.37*
p-Elk-1 1 ± 0.19 1.08 ± 0.54 2.18 ± 0.09*
p-c-Jun 1 ± 0.49 1.81 ± 0.25 1.88 ± 0.27
Notes: Data presented as mean ± SEM, n = 4; *p  0.05 when comparing DSP with 
DMSO control.
Abbreviations: DMSO, dimethyl sulfoxide; DSP, cigarette smoke particles.Vascular Health and Risk Management 2009:5 338
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We have studied the time course of DSP and the DSP 
dose-dependent effects previously8,16,22 The results show that 
DSP dose-dependently triggers the arterial smooth muscle 
cells and induces effects starting at concentration 0.1 μl/ml 
and reaching its maximal effect at 0.2 μl/ml and declining 
at 0.4 μl/ml. The time course study shows that DSP induces 
activation (phosphorylation) of p38 within 3 h and further 
increasing the activation during 24 h. This is associated 
with upregulation of ETB receptor protein expression at 6 h, 
assessed by Western blot in the arterial smooth muscle cells. 
The ETB receptor upregulation is further increased up to 24 h 
at functional and protein levels (contractile response and 
immunohistology).16 Based on above studies, we used DSP 
0.2 μl/ml (containing 20 ng/ml of nicotine, equivalent to the 
plasma level in smokers) for the present study.18
Smoke is associated with increased risk of cerebral and 
cardiovascular diseases including stroke and myocardial 
infarction1,6 So far, little is known about the signaling 
mechanisms of smoke-induced vascular dysfunction and 
damage. Studies have showed that smoke extracts23 and 
acrolein,24 a well known toxic substance in tobacco smoke, 
could stimulate phosphorylation of the p38 MAPK protein in 
the vascular cells. We investigated activation (phosphoryla-
tion) of MAPK and their downstream transcriptional factors 
in the cerebral arteries and showed that while ERK 1/2 and 
SAPK/JNK activations were not seen in the fresh cerebral 
arteries, they were strongly activated by an organ culture 
per se with DMSO. Adding DSP did not further increase the 
activation of ERK 1/2 and SAPK/JNK. The p38 was likewise 
not active in fresh arteries and the incubation of the cerebral 
arteries together with DMSO caused only a minor activa-
tion; the addition of DSP strongly augmented the activation 
of p38. The activation of c-Jun followed the pattern shown for 
SAPK/JNK and ERK 1/2, there being a strong activation in 
control cerebral arteries (treated with DMSO), but no further 
activation induced by DSP. ATF-2 and Elk-1, on the other 
hand, displayed only a minor activation in control cerebral 
arteries and DSP caused a strong activation of them. Thus, 
the present study demonstrates that DSP induces activation of 
the p38 MAPK inﬂ  ammatory signaling and phosphorylation 
of its downstream transcription factors (ATF-2 and Elk-1). 
This might be associated with the increased mRNA expres-
sion for MPP9, MMP13 and AT1 receptors induced by DSP. 
However, ERK 1/2 and the SAPK/JNK MAPK activities 
were markedly increased in the control and DSP did not result 
in further increase in their activities (Table 2).
Inﬂ  ammatory responses of cerebral blood vessels and 
increased MMP activity play key roles in cerebralvascular 
disease, particularly in formation of intracranial aneurysm 
that leads to stroke. Although inﬂ  ammatory macrophages 
Figure 3 No p38 phosphorylation was found in the fresh cerebral arteries, while a slight increase was obtained in the cerebral arteries treated with DMSO and a strong 
activation in the cerebral arteries treated with DSP,   ATF-2 and Elk-1 showed the same pattern as the p38 phosphorylation. However, phosphorylation of Elk-1 was also seen 
in the fresh cerebral arteries.
Abbreviations: DMSO, dimethyl sulfoxide; DSP, cigarette smoke particles.Vascular Health and Risk Management 2009:5 339
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and lymphocytes inﬁ  ltrate the aneurysm wall, a link between 
their presence and aneurysm growth with subsequent rup-
ture is not completely understood.25 The present study, by 
using organ culture of cerebral arteries in the presence of 
lipid-soluble cigarette smoke particles, has for the ﬁ  rst time 
demonstrated that in the cerebral arteries, lipid-soluble ciga-
rette smoke particles induced activation of the p38 MAPK 
intracellular inﬂ  ammatory signaling and phosphorylation of 
its downstream transcriptional factors (ATF-2 and Elk-1), 
enhanced the expression of extracellular-matrix-related 
gene MMP13 and upregulation of vascular AT1 receptors. 
Thus, organ culture of cerebral arteries in the presence of 
lipid-soluble cigarette smoke particles provides an ex vivo 
model of cerebral vessel inﬂ  ammation, which can be used as 
a surrogate for studying cerebrovascular inﬂ  ammation and 
the underlying molecular mechanisms involved.
MMP can degrade components of the arterial wall extra-
cellular matrix and involve in the pathogenesis of cerebral 
aneurysm formation and rupture. Serum MMP9 levels 
increase in SAH patients and returns to the normal level by 
the day 12 of post-SAH.26 More importantly, local changes 
in metalloprotease activity in the cerebral vasculature are 
considered as a key event in cerebral aneurysm formation and 
rupture in SAH.27 In the present study, we found a signiﬁ  cant 
upregulation of the metalloproteinases MMP9 and MMP13. 
MMP9 has previously been seen in cerebral ischemia,28 and 
thought to be associated with breakdown of the blood–brain 
barrier.29 MMP13, on the other hand, has been found to 
participate in inﬂ  ammatory responses.30 The increase in 
the amount of MMP13 protein present in the arterial walls 
following exposure to DSP suggests that there is a putative 
degradation of the basal lamina. This is supported by the 
observation that the smoke extracts may cause recruitment of 
the MMP secreting immune cells.28 The enhanced expression 
of MMPs might increase the inﬂ  ammatory response in the 
arteries, alter the function of the blood-brain barrier and result 
in the inﬂ  ux of the inﬂ  ammatory cells in smokers.
Cigarette smoke contains more than 4000 substances with 
many toxic chemicals that may cause vascular damage. We 
have studied the effects of DMSO-soluble (lipid-soluble), 
water-soluble cigarette smoke particles and nicotine per se 
on vasculature.16 Recently, heptane-soluble, DMSO-soluble 
and water-soluble cigarette smoke particles and their effects 
on G-protein coupled receptor expression were investigated 
(unpublished data). These results show that it is the lipid-
soluble cigarette smoke particles, but not water soluble or 
Figure 4 Immunohistochemistry shows a signiﬁ  cant increase in the amount of phosphorylated MMP13 proteins and AT1 receptor proteins in the cerebral arteries treated 
with DSP, compared with the control (DMSO-treated cerebral arteries). However, there was no increase in AT2 receptor proteins induced by DSP.
Notes: The size marker represents 20 μm.
Abbreviations: AT, angiotensin receptor; DMSO, dimethyl sulfoxide; DSP, cigarette smoke particles; MMP, matrix metalloproteinase.Vascular Health and Risk Management 2009:5 340
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nicotine per se, increase the gene expression for G-protein 
coupled receptors in the arterial smooth muscle cells16,22 as 
well as induce damage of the endothelium and its functions.31 
AT1 receptors mediate strong contraction of arteries and 
involve in vascular inﬂ  ammation.32 The enhanced expres-
sion of AT1 receptors occurs in the cerebral arteries from 
experimental ischemic stroke, and inhibition of the enhanced 
AT1 receptor expression results in reduction of the infarct 
volume.33 Sustained blockade of AT1 receptors with periph-
eral and centrally active AT1 receptor antagonists reverses 
the pathological hypertrophy and cerebrovascular inﬂ  am-
mation in spontaneously hypertensive rats.34 In the present 
study, DSP enhanced the expression of AT1 receptors in the 
smooth muscle cells of the cerebral arteries. This suggests a 
role of AT1 receptor overexpression that might be involved 
in cerebral inﬂ  ammation and dysfunction in smokers.
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